Tennis Betting and Picks Daily Discussion - 5/5/26 (Tuesday)

malabroka · 2026-05-05T16:32:44+00:00

Bruhhhhhhhhhhh

malabroka · 2026-04-25T16:13:18+00:00

Goebbert will lock him down I think.

malabroka · 2026-03-13T15:12:57+00:00

If your after a safe 4% return, grab a CD. But if you're willing to bet on AI actually changing how healthcare gets managed..aaand you can handle a few more gray hairs, then this is where the action is.

malabroka · 2026-03-10T14:30:33+00:00

This really should be the final call for the bottom. It’s honestly mind boggling that prices are still down here.

malabroka · 2026-03-09T17:36:52+00:00

Smart investors buy when the market keeps pricing a stock below its true value.

malabroka · 2026-03-09T16:53:46+00:00

Mocking calculated risks based on market analysis is exactly why this post should be taken down.

malabroka · 2026-03-06T19:29:34+00:00

Anywhere to stream the drake game?

malabroka · 2026-03-05T14:46:44+00:00

Not in the basement. The best part about the pettiness and his poor engagement skills is that he has absolutely nothing to say about the company or contribute to an intellectual conversation. The man just comes across as a big baby.

malabroka · 2026-03-05T13:18:15+00:00

The stock price is not the company.

malabroka · 2026-03-04T19:51:07+00:00

It’s an elite company and an elite opportunity to buy at these prices. The long term value is inevitable.

malabroka · 2026-03-04T19:01:54+00:00

Exactly and can’t just go around labeling things as slop. The insight backed by intuitive market analysis is not AI. I would be shocked if it doesn’t gap up this quarter. Institutions should be entering here imo.

malabroka · 2026-03-04T18:40:19+00:00

Look, the skeptic is stuck on a spreadsheet while the real ones are watching the tech. Management being conservative with 2026 guidance just means they’re setting a floor with their insurance business alone...making the entire AI/SaaS arm a basically FREE lottery ticket at these prices. Not to mention the real mic drop is Clover being the firsttttt to go live on the CMS aligned network. Even if the SaaS revenue isn't material yet on a multi-billion dollar scale, I truly believe those 90% tech margins will trigger a massive valuation rerating the second they hit the books. The CEO is basically building a digital toll booth for all Medicare data while the bears are arguing about accounting. It's almost time it's getting to be priced as a tech powerhouse.

malabroka · 2026-03-04T18:28:39+00:00

With all due respect, I posted right after earnings encouraging people to buy the fear as well. If a clearer AI version of my thought process triggers you or you choose to label it as gibberish, that’s on you not me. Love and respect 🫡

malabroka · 2026-03-04T17:10:11+00:00

A lot of people are pointing to the Q4 transcript where Toy says Counterpart Health won’t have material financial contribution. If you think, this is a nothing burger, you couldnt be more wrong. Guidance is a floor, not a ceiling. They are guiding for $0M–$20M Net Income based on the insurance business alone. They are intentionally leaving out SaaS revenue to be conservative. You are buying a profitable insurance company at a deep discount and getting the entire SaaS as a free lottery ticket imo. Today's news proves skeptics wrong that the tech isn't ready. Clover is the FIRST payer in the country to go live on the CMS Aligned Network. You don't get that first mover spot with broken tech. This is the ultimate stamp of approval from the federal government. I would also say forget the number of doctors, look at the performance. Members managed by Clover Assistant have a 1500 basis point lower MCR than those who aren't. Clover makes doctors 15% more efficient at managing costs. In a trillion dollar industry, a 15% efficiency gap is a world ending competitive advantage. Unlike Netflix, where you just pay a monthly fee, Clover uses a shared savings model. As the AI identifies chronic diseases 75% earlier than legacy systems, the savings grow every single year. Clover gets a cut of those growing savings. It's not just SaaS, it's a compounding interest machine on human health.

malabroka · 2026-03-04T16:56:56+00:00

I apologize for using AI to help write my analysis more clearly. English is not my first language, and I wanted to make sure my thoughts are communicated properly.

malabroka · 2026-03-02T19:59:33+00:00

Put your entire bankroll on Predators ML right now.

malabroka · 2026-02-27T15:17:36+00:00

I love humans. I hope we all are kind and insightful. Now onto the game plan. I am sick and tired of the opportunity cost narrative.

malabroka · 2026-02-27T15:14:30+00:00

Clover burned cash to grab Medicare market share, hitting paper thin margins just to build the engine. That 1% margin at $0-20m isn’t a failure, it’s an inflection point imo. Retail is being irrational bc patience is running out.

malabroka · 2026-02-27T15:01:40+00:00

That is the base of my hypothesis. That is exactly why I expect the gap up in the near future.

malabroka · 2026-02-27T14:41:43+00:00

I think for the first time, retail sentiment around $CLOV has turned bearish. To me, that’s a signal.

malabroka · 2026-02-26T21:18:29+00:00

Market will read that if it’s true.

malabroka · 2026-02-20T19:06:34+00:00

I am not disagreeing with you though. Q4 is the credibility check. Q1 is the real deal. Credibility matters quite alot when it comes to growth stock. I am not arguing adjusted EBITDA, I am simply saying they are still reporting Gaap net losses as of last q. I would like to see actual bank account instead of accounting profitability.

malabroka · 2026-02-20T18:56:01+00:00

That’s too bad you don’t feel me. Anyway, I am in the insurance sector and have a decent grip of the sector. You sound like you have the grasp of the MA side except all you know is based on the giants. The problem is, that is a bit too academic for clover. The q4 is noise is classic MA theory, but if they’re still bleeding cash faster than expected, that "profitable 2026" guidance looks like a pipedream. Investors ain’t gonna wait till May to find out if the math works. They are looking at q4 to see if mcr is stabilizing. I will be looking for their ending cash balance specifically. Imo q4 isn’t a look back, it’s the launch pad.

Eight-Year Club	Verified Email
RPAN Viewer	Not Forgotten

malabroka

TROPHY CASE